About this trial
To evaluate the clinical efficacy of the real-world Liuwei Dihuang pills for the treatment of female menopausal syndromes, and to provide a basis for effective, safe and rational clinical use of the drug.
Eligibility criteria
Qualifiers
Age: 45-55 years old
Patients with menopausal syndrome using Liuwei Dihuang Pills
Kidney Yin Deficiency Syndrome
Disqualifiers
Individuals allergic to any components of the drug or excipients;
Individuals with other endocrine diseases;
Individuals with organic lesions of the reproductive system;
Individuals who have undergone bilateral oophorectomy, hysterectomy, or have ovarian dysfunction;
Trial design
Treatments tested in this trial
- Liuwei Dihuang pills
Treatment groups
Locations
Sponsors and collaborators
China Academy of Chinese Medical Sciences
Lead sponsor
Lanxi Hospital of Traditional Chinese Medicine
Collaborator
First Affiliated Hospital of Harbin Medical University
Collaborator